UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 195

Sortiert nach

Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease

Neuropsychopharmacology (New York, N.Y.), 2019-04, Vol.44 (5), p.837-849

2019

Link zum Volltext

Verfügbarkeit prüfen

Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients

Molecular psychiatry, 2013-10, Vol.18 (10), p.1067-1076

2013

Link zum Volltext

Verfügbarkeit prüfen

Antidepressants and prolonged stress in rats modulate CAM-L1, laminin, and pCREB, implicated in neuronal plasticity

Neurobiology of disease, 2005-11, Vol.20 (2), p.432-441

2005

Link zum Volltext

Verfügbarkeit prüfen

Psychotropic and neurological medication effects on mitochondrial complex I and IV in rodent models

European neuropsychopharmacology, 2019-09, Vol.29 (9), p.986-1002

2019

Link zum Volltext

Verfügbarkeit prüfen

Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases?

Journal of neurochemistry, 1994-09, Vol.63 (3), p.793-807

1994

Link zum Volltext

Verfügbarkeit prüfen

State-dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia

Molecular psychiatry, 2002-01, Vol.7 (9), p.995-1001

2002

Link zum Volltext

Verfügbarkeit prüfen

Complex I impairments in schizophrenia; a complex story

European neuropsychopharmacology, 2016-10, Vol.26, p.S357-S357

2016

Link zum Volltext

Verfügbarkeit prüfen

Dopamine toxicity involves mitochondrial complex I inhibition: implications to dopamine-related neuropsychiatric disorders

Biochemical pharmacology, 2004-05, Vol.67 (10), p.1965-1974

2004

Link zum Volltext

Verfügbarkeit prüfen

Influence of neuromelanin on oxidative pathways within the human substantia nigra

Neurotoxicology and Teratology, 2002-09, Vol.24 (5), p.621-628

2002

Link zum Volltext

Verfügbarkeit prüfen

Induced pluripotent stem cells from hair follicles as a cellular model for neurodevelopmental disorders

Stem cell research, 2012, Vol.8 (1), p.134-140

2012

Link zum Volltext

Verfügbarkeit prüfen

The possible role of iron in the etiopathology of parkinson's disease

Movement disorders, 1993, Vol.8 (1), p.1-12

1993

Link zum Volltext

Verfügbarkeit prüfen

Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?

Acta neurologica Scandinavica, , Vol.80 (s126), p.47-54

Link zum Volltext

Verfügbarkeit prüfen

The Iron Chelator Desferrioxamine (Desferal) Retards 6‐Hydroxydopamine‐Induced Degeneration of Nigrostriatal Dopamine Neurons

Journal of neurochemistry, 1991-04, Vol.56 (4), p.1441-1444

1991

Link zum Volltext

Verfügbarkeit prüfen

Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine

Journal of neurochemistry, 2002-12, Vol.83 (6), p.1241-1251

Ben‐Shachar, Dorit

2002

Link zum Volltext

Verfügbarkeit prüfen

P.2.016 A possible involvement of opioid degrading enzymes in individual reactivity to acute traumatic stress

European neuropsychopharmacology, 2010, Vol.20, p.S41-S42

2010

Link zum Volltext

Verfügbarkeit prüfen

Mitochondrial complex i subunits expression is altered in schizophrenia: a postmortem study

Biological psychiatry (1969), 2004-04, Vol.55 (7), p.676-684

2004

Link zum Volltext

Verfügbarkeit prüfen

Ironing Iron Out in Parkinson's Disease and Other Neurodegenerative Diseases with Iron Chelators: A Lesson from 6-Hydroxydopamine and Iron Chelators, Desferal and VK-28

Annals of the New York Academy of Sciences, 2004-03, Vol.1012 (1), p.306-325

2004

Link zum Volltext

Verfügbarkeit prüfen

Mitochondria, Synaptic Plasticity, And Schizophrenia

Disorders of Synaptic Plasticity and Schizophrenia, 2004, Vol.59, p.273-296

2004

Link zum Volltext

Verfügbarkeit prüfen

P.1.06 Impaired mitochondrial respiration due to dopamine inhibition of complex I activity: implication to schizophrenia

European neuropsychopharmacology, 2008, Vol.18, p.s6-s7

2008

Link zum Volltext

Verfügbarkeit prüfen

Role of iron and iron chelation in dopaminergic-induced neurodegeneration: Implication for Parkinson's disease

Annals of neurology, 1992, Vol.32 (S1), p.S105-S110

1992

Link zum Volltext

Verfügbarkeit prüfen

Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats

Neuropharmacology, 2004-02, Vol.46 (2), p.254-263

2004

Link zum Volltext

Verfügbarkeit prüfen

Transcranial magnetic stimulation induces alterations in brain monoamines

Journal of Neural Transmission, 1997-01, Vol.104 (2-3), p.191-197

1997

Link zum Volltext

Verfügbarkeit prüfen

P.1.09 DA affects mitochondrial function via its interaction with complex I: implications to schizophrenia

European neuropsychopharmacology, 2007, Vol.17, p.S9-S10

2007

Link zum Volltext

Verfügbarkeit prüfen

ATF2, A Member of the CREB ATF Family of Transcription Factors, in Chronic Stress and Consequent to Antidepressant Treatment: Animal Models and Human Post-Mortem Brains

Neuropsychopharmacology (New York, N.Y.), 2004-03, Vol.29 (3), p.589-597

2004

Link zum Volltext

Verfügbarkeit prüfen

P.1.10 A complex norepinephrine and glucocorticoid intercellular interaction: relevance to plasticity hypothesis of depression

European neuropsychopharmacology, 2007, Vol.17, p.S10-S11

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 195

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(186)
Mit Volltextzugriff
(166)

Publikationsform

Sprache

Englisch
(195)
Japanisch
(25)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease

Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients

Antidepressants and prolonged stress in rats modulate CAM-L1, laminin, and pCREB, implicated in neuronal plasticity

Psychotropic and neurological medication effects on mitochondrial complex I and IV in rodent models

Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases?

State-dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia

Complex I impairments in schizophrenia; a complex story

Dopamine toxicity involves mitochondrial complex I inhibition: implications to dopamine-related neuropsychiatric disorders

Influence of neuromelanin on oxidative pathways within the human substantia nigra

Induced pluripotent stem cells from hair follicles as a cellular model for neurodevelopmental disorders

The possible role of iron in the etiopathology of parkinson's disease

Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?

The Iron Chelator Desferrioxamine (Desferal) Retards 6‐Hydroxydopamine‐Induced Degeneration of Nigrostriatal Dopamine Neurons

Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine

P.2.016 A possible involvement of opioid degrading enzymes in individual reactivity to acute traumatic stress

Mitochondrial complex i subunits expression is altered in schizophrenia: a postmortem study

Ironing Iron Out in Parkinson's Disease and Other Neurodegenerative Diseases with Iron Chelators: A Lesson from 6-Hydroxydopamine and Iron Chelators, Desferal and VK-28

Mitochondria, Synaptic Plasticity, And Schizophrenia

P.1.06 Impaired mitochondrial respiration due to dopamine inhibition of complex I activity: implication to schizophrenia

Role of iron and iron chelation in dopaminergic-induced neurodegeneration: Implication for Parkinson's disease

Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats

Transcranial magnetic stimulation induces alterations in brain monoamines

P.1.09 DA affects mitochondrial function via its interaction with complex I: implications to schizophrenia

ATF2, A Member of the CREB ATF Family of Transcription Factors, in Chronic Stress and Consequent to Antidepressant Treatment: Animal Models and Human Post-Mortem Brains

P.1.10 A complex norepinephrine and glucocorticoid intercellular interaction: relevance to plasticity hypothesis of depression

Suchergebnisse filtern